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S U M M A R Y
Objective: To evaluate risk factors for in-patient treatment interruptions (TIs) in Russian tuberculosis
(TB) hospitals.
Methods: The regional case-based registers for all TB patients registered in the main regional TB
hospitals were analyzed for the period 1993–2002. Multivariable analysis of risk factors for TIs was
performed using logistic regression. The prediction rule was developed based on the ﬁnal multivariable
model coefﬁcients obtained from analysis of the largest (Lipetsk) database.
Results: During the study period, 18–50% of new cases and 36–56% of retreatment cases had interrupted
in-patient treatment. In multivariate analysis, independent predictors of treatment interruption
included: male gender (odds ratios (ORs) 1.5–2.3), age group 25–50 years (ORs 1.5–1.7), alcohol abuse
(ORs 1.8–4.0), imprisonment history (ORs 1.3–2.5), unemployment (ORs 1.1–2.8), being a retreatment
case (ORs 1.3–2.5), and having severe forms of TB (1.4–4.0); factors protective from interruption
included urban residence (ORs 0.7–0.9) and having concomitant diseases (ORs 0.6–0.8). Based on the
Lipeck model, new TB cases from the four regions were divided into low, high, and very high risk groups.
Proportions of TI were approximately 20–35% in the low risk group, approximately 60–75% in the high
risk group, and approximately 75–85% in the very high risk group (except Orel).
Conclusions: Wehave described the independent predictors of patient TI, and a predictive rule for the in-
patient TB treatment phase interruptions has been developed. Treatment interruption is a signiﬁcant
obstacle in the success of the National Tuberculosis Control Program in Russia. Interventions targeted at
the high risk groups should be implemented in order to prevent in-patient treatment interruption.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Tuberculosis (TB) treatment interruptions (TIs) represent a
serious problem for effective TB control.1 TIs lead to an increase in
drug resistance at the individual and population levels, the
emergence of multi-drug resistance (MDR), and an increase in
the number of individuals with infectious TB, which increases the
risk of infection in the population.2,3 High levels of TI are also a
serious obstacle to treatment completion with second-line drugs
for the management of drug-resistant TB, including MDR-TB. Non-
compliance with second-line drug treatment protocols can create
the threat of ‘super’ drug resistance, including extensively drug-
resistant (XDR) TB.4
Tuberculosis is a major public health problem in Russia. Russia
is included on the World Health Organization (WHO) list of the 22* Corresponding author. Tel.: +41 22 791 2485; fax: +41 22 791 1589.
E-mail address: jakubowiakw@who.int (W.M. Jakubowiak).
1201-9712/$36.00 – see front matter . Published by Elsevier Ltd on behalf of Internatio
doi:10.1016/j.ijid.2010.03.001TB high-burden countries.5 In 2004, TB notiﬁcation and TB
mortality rates registered in Russia returned to the rates observed
at the end of the 1960s, i.e., 83.1 and 21.4 per 100 000 population,
respectively.6 Preliminary data suggest that completion of TB
treatment regimens is a signiﬁcant problem in Russia.7 In 1999–
2001, TI rates among new TB cases in Russian regional TB hospitals
reached 40%.8 The ﬁndings of recent studies7,9 show that the in-
patient TI problem still exists following the modiﬁcation of the
Russian TB control system in 2003–2004 in accordance with the
WHO recommendations and the Russian Ministry of Health and
Social Development policy. Determining the risk factors for TB TI is
important for TB control worldwide and in Russia.
The implementation of an electronic TB surveillance system in
Russia (developed by the Research Institute of Phthisiopulmonol-
ogy (RIPP)) in 1991 has allowed new opportunities for in-depth
evidence-based analysis of TI using the routine case-based
registers.8 In Russia, the intensive phase of TB treatment is usually
in-patient, and the continuation phase of treatment is often out-nal Society for Infectious Diseases.
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in-patient TI in Russian TB hospitals.
2. Methods
2.1. Study design
The study was a retrospective population-based study of the
data for the period 1993–2002. The national TB electronic
surveillance system has been functioning in Russian regions since
1992, and includes in-patient treatmentmonitoring, which started
in 1993.10,11 Information entered into the in-patient treatment
control register is based on the standardized hospital discharge
form for the computerized surveillance system approved by the
Ministry of Health (MOH). Supervisory Federal TB institutes
routinely provide selective assessment of data quality. Data
validation was provided by the data collection software during
the data entry stage. According to the Russian National TB Control
Program guidelines and the Orders made during the study period,
all new TB cases and relapses must be treated on an in-patient
basis during the intensive phase; thus, a sample of the discharged
patients in Russian TB hospitals was representative of TB cases
registered in these regions.
Selected for the study of TB hospitals were the in-patient
departments of regional TB dispensaries (regional TB dispensaries
have in- and out-patient departments) responsible for TB
management (TB prevention, case ﬁnding, treatment and fol-
low-up) in the regions. These hospitals provide the intensive phase
of treatment for almost all registered TB patients in their
designated area. All TB patients from that area had to be
hospitalized during the intensive phase of treatment according
to State regulations. Five regions were selected from >20 Russian
regions with available TB discharge databases. Selectionwas based
on the use of TB databases for reporting for 4 years or more and
location of the TB hospital in the central part of Russia. As
recommended by the WHO, the ‘directly observed therapy short
course’ (DOTS) strategy was adopted in Russia in 2003–2004.12,13
DOTS was launched in the regions of Orel in 1999; other regions
did not have DOTS during the study period. Data were analyzed for
1993–2002 (prior to the implementation of the new treatment
standards in Russia in 2003). For patients with multiple
hospitalizations, only the ﬁrst admission to the TB hospital was
included. HIV rates (based onWestern blot conﬁrmation) in Russia
were lowduring the study period (less than 1% among all TB cases);
therefore TB/HIV co-infection did not have a signiﬁcant impact on
treatment outcomes.
The WHO TB Control Programme in Russia determined the
project to be non-research; ethical clearance was not required.
2.2. Patient population and deﬁnitions
Data on civilian patients aged 18 years with bacteriologically
conﬁrmed TB (positive acid-fast bacilli (AFB) sputum smear or
culture) and clinical TB (based on chest radiographic ﬁndings and
clinical examination criteria) were included in the analysis. Both
new and retreatment cases, pulmonary and extrapulmonary cases
were included. Patientswith treatment outcomes ‘transfer out’ and
‘death’ during TB treatment were excluded. Severe forms of
pulmonary TB were deﬁned according to an X-ray-based
classiﬁcation and included TB with intensive lung involvement,
cavitations, and/or ﬁbrosis (inﬁltrative cavernous, disseminated,
and miliary TB, caseous pneumonia and TB with extended lung
cavitations, and ﬁbrosis deﬁned as ‘ﬁbro-cavernous TB’ according
to the Russian classiﬁcation). Alcohol abuse status was deﬁned
according to the subjective assessment expertise of the attending
hospital doctor, responsible for patient data recording (alcoholabuse information based onWHO deﬁnition was not accessible for
registration and analysis). Concomitant diseases included cardio-
vascular disease, gastrointestinal tract disease, chronic obstructive
pulmonary disease, and renal, endocrine, nervous and musculo-
skeletal system diseases.
Prior to 2003, TB hospitals did not use standard DOTS
deﬁnitions, but used deﬁnitions of in-patient TI determined and
approved by the MOH in the process of the TB electronic
surveillance system implementation at the beginning of the
1990s. The ‘pre-DOTS’ TI deﬁnition reﬂected the TI phenomena
more comprehensively than the current DOTS TI deﬁnition, and
was deﬁned as complete interruption of the course of treatment for
two ormoremonths, or the intake of irregular TB drug doses during
two or more months as recorded by the attending physician.
We evaluated TI initiated by the patient (signiﬁcant non-
compliance with the doctor’s prescribed course of treatment and
serious violations of public order in hospitals) resulting in in-
patient treatment cancellation. Such TIs are recorded by the
attending physician on medical charts and reported to the TB
surveillance unit.
2.3. Statistical analysis
Statistical analyses were performed using SAS software, version
8.2 (SAS Institute Inc., Cary, NC, USA). A p-value of <0.05 was
deﬁned as statistically signiﬁcant. We selected a-priori for analysis
16 potential risk factors from more than 100 variables in the
databases based on the literature, pilot data, and plausibility of
their association with TI.
The Mantel–Haenszel odds ratios (ORs) and corresponding 95%
conﬁdence intervals (CIs) were calculated for dichotomous
variables. Multivariable modeling was performed using logistic
regression. Variables included in the initial model included age,
gender, residence (urban or rural), alcohol abuse, prison history,
social–occupational status (employed, unemployed, disabled,
retired, student), homelessness, TB history (retreatment or new
TB case), form of TB (pulmonary or extrapulmonary), bacteriologi-
cal and X-ray results, severe forms of TB, and concomitant diseases.
The prediction rule was developed based on the ﬁnal multivariable
model coefﬁcients obtained from the analysis of the largest
(Lipetsk) database. The Lipetsk database was used as a ‘training
dataset’ for testing of the prediction rule on databases from four
other regions (‘validation databases’). The quality of the prediction
rule (the ‘optimism’ of the performance of the prediction rule
reﬂecting differences between the training and testing data set)
was tested using the ‘bootstrap’ method.14 The bootstrap estima-
tion of the model coefﬁcients and the amount of ‘optimism’ in the
prediction rule was developed using the training set of 1000
repetitions of the procedures. The SAS codes, developed by S.
Shaykevich, were used for validation of the prediction rule.
Discrimination of the prediction rule developed on the Lipetsk
database was validated on ‘validation databases’ by estimation of
the receiver-operating characteristic (ROC) curves. For practical
use of the prediction rule, three groups were deﬁned depending on
the value of probability of TI (PTI): ‘low risk group’ (PTI 0.5), ‘high
risk group’ (0.5 < PTI  0.75), and ‘very high risk group’ (PTI > 0.75),
where the PTI is calculated by the predictive model.
3. Results
Data on 37 640 hospital discharges for 27 620 TB patients were
available; 17 295 records were included in the analysis based on
the study inclusion criteria (Table 1).
Demographic, social, and clinical descriptive data are shown in
Table 2. The majority of patients (76–80%) were male , with a
median age of 40–45 years. Retreatment cases accounted for 24–
Table 1
TB hospital discharge databases included in the study
Region Total number
of records in
database, N
Time period
included in
the analysis
Total number of
individual patients
with active TB, n
Number of records
(individual patients)
included in the
analysis, n
Number of new
TB cases included
in the analysis, n
Percentage of new
TB cases from all TB
cases included in
the analysis, %
Lipetsk 10 000 1995–2002 6534 4243 2892 68.2
Belgorod 4800 1994–2002 3730 2425 1894 78.1
Orel 7000 1998–2002 4537 3237 2228 68.8
Pskov 7140 1994–2002 6072 3340 2072 62.0
Yaroslavl 8700 1993–2002 6747 4050 2915 72.0
Total 37 640 1993–2002 27 620 17 295 12 001 69.4
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considerable variability in the prevalence of factors among
hospitalized TB patients for several variables, such as alcohol
abuse (4–31%), prison history (6–18%), unemployment (12–45%),
retirement (6–15%), and disability status (8–24%).
During the study period 18–50% of new cases and 36–56% of
retreatment cases had interrupted in-patient treatment (Table 3).
Among interrupted and discharged from hospital patients, 35–46%
of new and 50–60% of retreatment cases were bacteriologically
positive on discharge. The proportion of length of stay (LOS) for
interrupted patients from overall LOS (i.e., overall LOS of adherent
and interrupted treatment patients) ranged from 14–37% among
new cases to 29–45% among retreatment cases.
Among patients with interrupted treatment, 56–64% were in
the age group 25–50 years. In univariate analysis, signiﬁcant risk
factors for TI in all ﬁve regions included: male gender (ORs 2.8–
3.6), age group of 25–50 years (ORs 1.9–2.1), alcohol abuse (ORs
3.0–5.7), imprisonment history (ORs 3.2–4.5), homelessness (data
were available from Orel only, OR 5.4), unemployment (ORs 1.7–
3.4), retreatment cases (ORs 1.1–2.8), pulmonary TB (ORs 2.8–5.1),
being AFB sputum smear- or culture-positive (ORs 2.1–2.8),
cavitary lung disease (ORs 2.1–2.7), and severe forms of TB (ORs
2.5–3.5), depending on the region (Table 4). Factors protective
from TI included urban residence (ORs 0.6–0.9), being retired (ORs
0.4–0.6), being a student (ORs 0.05–0.17), and having concomitant
diseases (ORs 0.6–0.8) for the different regions.
Multivariable logistic regression modeling was done separately
for each regional hospital. Independent predictors of TI included:
male gender (ORs 1.5–2.3), age group 25–50 years (ORs 1.5–1.7),
alcohol abuse (ORs 1.8–4.0), imprisonment history (ORs 1.3–2.5),
unemployment (ORs 1.1–2.8), being a retreatment case (ORs 1.3–Table 2
Descriptive data for the TB in-patients in the Russian regional TB hospitals
Factors Lipetsk, n (%) Belgorod, n (%)
Demographic and social data
Male gender 3259 (76.8) 1870 (77.1)
Age, median, years 45 40
Urban residence 1683 (39.9) 1631 (67.3)
Alcohol abuse 170 (4.0) 119 (4.9)
Imprisonment history 335 (7.9) 136 (5.6)
Unemployed 779 (18.6) 282 (11.7)
Disabled 1000 (23.9) 318 (13.2)
Retired 611 (14.6) 210 (8.7)
Student 33 (0.8) 48 (2.0)
Homeless – –
Clinical data
Retreatment cases 1400 (33.3) 589 (24.3)
Pulmonary TB 3187 (78.6) 2043 (88.9)
Concomitant diseases 2355 (55.5) 667 (27.5)
AFB sputum smear- or culture-positivea 2188 (55.7) 1378 (57.2)
Cavitary disease 1507 (50.6) 1158 (57.0)
Severe pulmonary TB forms 1536 (36.2) 931 (38.4)
AFB, acid-fast bacillus.
a Referent group AFB sputum smear- and culture-negative.2.5), and having severe forms of TB (ORs 1.4–4.0). Factors
protective from interruption included urban residence (ORs 0.7–
0.9) and having concomitant diseases (ORs 0.6–0.8) (Table 5).
The predictive rule to calculate the probability of TI for values
of deﬁned factors were obtained based on a ﬁnal logistic
regression model for Lipetsk TB hospital data (expression 1): log
[PTI/(1  PTI)] = 3.2 + 0.8*(male gender) + 0.7*(unemployment) +
0.4*(retreatment case) + 1.1*(alcohol abuse) + 0.6*(no data about
alcohol abuse) + 0.8*(severe TB form)  0.3*(urban residen-
ce) + 0.4*(age 25–50) + 0.8*(pulmonary TB) + 0.5*(prison history),
where PTI is the probability of TI and every predictor has a value of
‘1’ if that characteristic or event is present or ‘0’ if it is not present.
The prediction rule performed well in the testing sets using
cross-validation (bootstrapping) re-sampling techniques (param-
eter of optimism 0.007), and discrimination of the rule estimated
using ROC curveswas good (the areas under the curves showed the
discrimination of the developed rule from 0.75 to 0.78) (Figure 1).
Distribution of the patients into low risk, high risk, and very
high risk groups was used to calibrate testing of the prediction rule
for TI (using the Lipetsk data) for the four other TB hospital
databases (Table 6). Treatment interruption in the Lipetsk patients
assigned to the high and very high risk groups by the predictive
rule, occurred in approximately 60–80% of cases. Based on the
Lipeck model, new TB cases from the four other regions were
divided into the three risk groups – low, high, and very high risk.
The proportions of TI in each risk group are shown in Table 6.
Similar results were found in all TB hospitals; approximately 20–
35% of TIs occurred in the low risk group, approximately 60–75%
occurred in the high risk group, and approximately 75–85%
occurred in the very high risk group (with the exception of Orel:
approximately 40% for the high risk group, approximately 50% forOrel, n (%) Pskov, n (%) Yaroslavl, n (%) Total, n (%)
2522 (77.9) 2669 (79.9) 3094 (76.4) 13 414 (77.6)
44.5 44 42 –
1605 (50.3) 2041 (62.2) 3254 (82.0) 10 213 (59.9)
1010 (31.2) 1025 (30.7) 814 (20.1) 3138 (18.1)
573 (17.7) 391 (11.7) 737 (18.2) 2172 (12.6)
1457 (45.4) 1286 (38.5) 713 (17.6) 4516 (26.3)
250 (7.8) 785 (23.5) 449 (11.1) 2803 (16.3)
395 (12.3) 314 (9.4) 235 (5.8) 1765 (10.3)
21 (0.7) 40 (1.2) 28 (0.7) 170 (1.0)
45 (1.4) – – –
1029 (31.8) 1266 (37.9) 1175 (29.0) 5458 (31.6)
2801 (87.7) 2826 (87.6) 3248 (82.6) 14 105 (84.4)
774 (23.9) 935 (28.0) 822 (20.3) 5553 (32.1)
2192 (68.0) 2017 (61.2) 1805 (46.4) 9581 (57.1)
1626 (58.3) 2128 (75.5) 1964 (62.0) 8383 (60.4)
1615 (49.9) 1937 (58.0) 1920 (47.4) 7939 (45.9)
Table 3
TB treatment interruptions in Russian TB hospitals
Regional TB hospital Lipetsk Belgorod Orel Pskov Yaroslavl Total
New cases
Total patients, N 2762a 1894 2228 2072 2915 11 871
Treatment interruption rate, % 33.0 23.0 17.7 49.5 35.6 32.0
Proportion of AFB smear/culture-positive on discharge (at the end
of the interrupted course of treatment) among interrupted patients, %
45.1 42.1 35.0 45.7 43.2 43.4
Mean LOS for interrupted patients, days per patient 97.4 89.6 124.4 102.8 75.9 94.6
Mean LOS for non-interrupted patients, days per patient 133.2 169.6 170.9 178.1 126.6 152.1
Proportion of LOS of interrupted patients from overall LOS,b % 26.8 13.8 13.7 37.1 25.4 23.3
Retreatment cases
Total patients, N 1142a 491a 952a 1125a 1036a 4746a
Treatment interruption rate, % 36.3 45.8 37.6 56.4 51.2 45.5
Proportion of AFB smear/culture-positive on discharge (at the end
of the interrupted course of treatment) among interrupted patients, %
55.3 60.0 57.0 50.2 53.0 54.0
Mean LOS for interrupted patients, days per patient 89.8 71.5 90.3 86.0 68.1 81.3
Mean LOS for non-interrupted patients, days per patient 85.1 132.4 128.3 144.0 111.1 114.6
Proportion of LOS of interrupted patients from overall LOS,b % 36.2 34.1 29.3 44.9 39.3 37.3
AFB, acid-fast bacillus; LOS, length of stay.
a Number of patients with available information for variables included in the table.
b The proportion of LOS for interrupted patients from overall LOS was calculated as number of days that interrupted patients stayed in the hospital before interruption
divided by the total number of days spent in hospital by all patients (adherent and those with interrupted treatment) during the study period, reported as a percentage.
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group).
4. Discussion
The implementation of electronic case-based TB surveillance
systems in Russia has provided opportunities to use evidence-
based methods in TB service practice. However, databases in TB
dispensaries are usually only used for the annual national reports
and routine TB surveillance. This study demonstrates the potential
for operational research using routine TB data collection systems.
The data provided by the large number of discharge summaries
recorded in ﬁve central Russian TB hospital databases demonstrate
that patient TIs represent a signiﬁcant problem. Patient TI rates in
hospitals were high in all study regions (18–50% for new cases and
36–56% for retreatment cases). The majority of patients who
interrupted treatment were smear/culture-positive at the end of
the interrupted in-patient treatment (35–46% among new casesTable 4
Univariate analysis of risk factors for treatment interruption
Lipetsk
OR (95% CI)
Belgorod
OR (95%
Demographics and social data
Male gender (vs. female) 3.5 (2.9–4.3) 3.6 (2.7–
Urban residence (vs. rural) 0.6 (0.5–0.6) 0.7 (0.6–
Age group 25–50 yearsa 2.0 (1.8–2.3) 2.0 (1.6–
Alcohol abuse 4.0 (2.9–5.5) 5.7 (3.9–
Imprisonment history 3.8 (3.0–4.8) 4.5 (3.1–
Homelessness N/A N/A
Unemploymentb 2.6 (2.3–3.1) 2.9 (2.2–
Retiredb 0.6 (0.5–0.7) 0.6 (0.4–
Studentb 0.06 (0.0–0.4) 0.17 (0.1
Clinical data
Retreatment cases (vs. new cases) 1.1 (1.0–1.3) 2.8 (2.3–
Pulmonary TB (vs. extrapulmonary TB) 5.1 (4.1–6.3) 3.0 (2.0–
Concomitant diseases 0.8 (0.7–0.9) 0.7 (0.6–
AFB sputum smear- or culture-positivec 2.8 (2.4–3.2) 2.1 (1.7–
Cavitary disease (vs. no caverns) 2.3 (2.0–2.6) 2.2 (1.8–
Severe forms of pulmonary TB 3.5 (3.1–4.0) 3.5 (2.9–
OR, odds ratio; CI, conﬁdence interval; N/A, data not available.
a Referent group included patients aged <25 years and >50 years.
b Referent group included remainder patients (i.e. employed, not retired, not studen
c Referent group AFB sputum smear- and culture-negative.and 50–60% among retreatment cases), thus creating a risk of
signiﬁcant TB exposure for their contacts.
Multivariable logistic regression modeling was done separately
for every regional hospital, since the association between risk
factors and TI may differ from region to region (or between
regional hospitals) due to the various social and economical levels
or living standards and quality of health services. Independent
predictors of TI in all regions included: male gender, age group 25–
50 years, alcohol abuse, imprisonment history, unemployment,
being a retreatment case, and having severe forms of TB. Factors
protective from interruption included urban residence and having
concomitant diseases. Data from four TB hospitals (Pskov,
Yaroslavl, Belgorod, and Lipetsk) showed particularly similar
results, while Orel data showed similar patterns, but slightly
weaker strength of associations. Some of the differences in the data
between Orel and the other regions could be related to the
implementation of the DOTS strategy in the region of Orel during
the study period. This could also explain the ﬁnding that only oneCI)
Orel
OR (95% CI)
Pskov
OR (95% CI)
Yaroslavl
OR (95% CI)
4.8) 2.8 (2.2–3.6) 2.9 (2.4–3.4) 2.8 (2.4–3.3)
0.9) 0.8 (0.7–1.0) 0.9 (0.8–1.1) 0.7 (0.6–0.8)
2.4) 2.0 (1.7–2.4) 2.1 (1.9–2.5) 1.9 (1.7–2.2)
8.4) 3.0 (2.5–3.5) 5.1 (4.3–6.0) 5.6 (4.7–6.6)
6.4) 3.4 (2.8–3.1) 3.2 (2.5–4.1) 4.0 (3.3–4.7)
5.4 (2.9–9.9) N/A N/A
3.7) 3.4 (2.9–4.0) 3.2 (2.7–3.7) 1.7 (1.5–2.0)
0.8) 0.4 (0.3–0.6) 0.4 (0.3–0.5) 0.5 (0.3–0.6)
–0.6) 0.16 (0.0–1.2) 0.05 (0.0–0.2) 0.06 (0.0–0.4)
3.4) 2.8 (2.4–3.4) 1.2 (1.0–1.4) 1.8 (1.6–2.1)
4.3) 4.2 (2.9–6.1) 4.8 (3.7–6.1) 2.8 (2.3–3.4)
0.9) 0.6 (0.5–0.7) 0.7 (0.6–0.8) 0.6 (0.6–0.8)
2.5) 2.4 (2.0–2.9) 2.2 (1.9–2.5) 2.4 (2.1–2.7)
2.6) 2.1 (1.8–2.5) 2.4 (2.1–2.9) 2.7 (2.3–3.1)
4.3) 2.5 (2.1–3.0) 3.5 (3.0–4.0) 3.0 (2.6–3.4)
t).
Table 5
Multivariable analysis of risk factors for treatment interruption
Region Lipetsk
aOR (95% CI)
Belgorod
aOR (95% CI)
Orel
aOR (95% CI)
Pskov
aOR (95% CI)
Yaroslavl
aOR (95% CI)
Male (vs. female) 2.1 (1.7–2.6) 2.3 (1.7–3.1) 1.5 (1.1–2.0) 1.8 (1.5–2.2) 1.7 (1.4–2.0)
Urban (vs. rural) 0.8 (0.7–0.9) 0.7 (0.6–0.9) a 0.9 (0.8–1.1) a
Age group 25–50 yearsb 1.5 (1.3–1.7) 1.7 (1.4–2.1) 1.5 (1.2–1.9) 1.5 (1.3–1.8) 1.6 (1.3–1.8)
Alcohol abuse 3.1 (2.3–4.2) 2.4 (1.5–3.8) 1.8 (1.5–2.2) 4.0 (3.3–4.9) 4.0 (3.2–4.8)
Imprisonment history 1.7 (1.2–2.6) 2.1 (1.4–3.2) 1.5 (1.2–1.9) 1.3 (0.95–1.7) 2.5 (2.0–3.1)
Unemployment 1.9 (1.6–2.3) 2.8 (2.1–3.8) 2.4 (2.0–3.0) 2.4 (2.0–2.8) 1.1 (0.9–1.3)
Retreatment (vs. new cases) 1.5 (1.2–1.7) 1.8 (1.4–2.3) 2.5 (2.0–3.0) 1.3 (1.1–1.6) 1.3 (1.1–1.5)
Severe pulmonary TB forms 2.2 (1.8–2.5) 4.0 (2.9–5.5) 1.4 (1.1–1.7) 2.3 (1.9–2.7) 1.9 (1.6–2.2)
Concomitant diseases 0.8 (0.7–0.9) 0.6 (0.5–0.8) 0.6 (0.4–0.7) 0.7 (0.6–0.8) a
aOR, adjusted odds ratio; CI, conﬁdence interval.
a Variable was dropped from the ﬁnal model because it was not statistically signiﬁcant.
b Reference group included patients aged <25 years and >50 years.
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with interruption in the Orel data compared to the other hospitals,
since the DOTS strategy implies more attention to new cases than
to the retreatment cases.
It is important to point out that the high level of TI is common in
other Russian TB hospitals not included in this study. Results of this
study were likely not impacted by the quality of service in the
studied hospitals, which have the best TB control practices among
TB services in Russia. Data from other TB hospitals demonstrate
similar results (RIPP, unpublished data from other 15 TB regional
hospitals), so this study has revealed some commonproblems of TB
management in Russian hospitals. Similar results were found in
the studied hospitals in spite of the fact that the prevalence of
factors among patients was sometimes signiﬁcantly different.
Thus, the ﬁndings of this study could be generalized to otherFigure 1. Comparison of the receiver-operating characteristic (ROC) curves for the
training set (Lipetsk) and validation sets (Pskov, Yaroslavl, Belgorod, and Orel).Russian regions, because it included large numbers of patients
discharged over a number of years.
Similar outcomes in several regions supported the idea of
developing a predictive rule for the deﬁnition of the high and the
very high risk groups for TI, which could be used in Russian TB
hospitals located in Central Russia. Treatment was actually
interrupted in 76–84% of the cases in the very high risk group
and 61–76% of the cases in the high risk group (according to the
predictive rule) in non-DOTS TB hospitals. Data from the DOTS
region (Orel) showed a smaller portion of actual TI in the very high
risk and high risk groups (50% and 37%, respectively). The DOTS TB
hospital data should be used to develop a separate predictive rule.
The predictive rule could be used as a practical tool for the
identiﬁcation of groups at risk of interruption for a targeted impact
on patient adherence using different interventions, including
social support. In addition, the predictive rule could be used for
selection and enrollment of TB patients in treatment with second-
line drugs (‘DOTS plus’). This may help to avoid creating ‘super
drug resistance’ as a result of TI.
TI also creates direct economic losses for TB hospitals because of
the expense of hospital services, time of personnel, and other
hospital expenses incurred for noncompliant patients (approxi-
mately 14–40% of in-patient days for new cases and 30–45% for
retreatment cases were spent treating patients who did not
complete in-patient therapy). The time and costs associated with
hospital treatment of these patients could be usedmore effectively
for targeted social support of patients in the high risk groups, to
encourage adherence.7 Because of especially high levels of
economic loss in hospitals due to the treatment of retreatment
TB cases (a signiﬁcant portion of which are chronic cases), the need
for organization of special departments to provide social support
should be emphasized.
5. Limitations
Our study is subject to several limitations. There may be data
scattering for several factors in the databases due not only to
differences in the distribution of the factors among the popula-
tions, but also to the quality of registers and to differences in
understanding of the deﬁnitions. To improve TB surveillance it is
necessary to use the WHO recommended deﬁnitions for each
factor (for example, for ‘alcohol abuse’). The study was also limited
by the assessment of only the in-patient phase of treatment. This
study analyzed only those patient factors that could explain poor
adherence and did not include any health service factors, such as
the quality of TB healthcare services, which were affected by the
economic crisis during the study period (drug shortages, low
salaries of the health staff); this could have resulted in a poor
quality of service and an increase in the risk of patient treatment
interruption. Also, hospitalization of all patients during the
Table 6
Calibration table: proportions of actual treatment interruptions in the three risk groups deﬁned by the predictive rulea,b
Treatment interruption risk groups
Low risk group*(PTI  0.5) High risk group*(0.5<PTI  0.75) Very high risk group*(PTI>0.75)
Treatment interruptions
Regions Total, N Patients classiﬁed
as low risk, n
% of these
interrupted
Patients classiﬁed
as high risk, n
% of these
interrupted
Patients classiﬁed
as very high risk, n
% of these
interrupted
Training data set:
Lipetsk 1363 734 25.2 541 58.7 88 77.2
Validation data sets:
Pskov 1634 691 35.3 695 75.9 248 83.5
Yaroslavl 1510 846 29.2 501 67.6 163 76.2
Belgorod 648 393 20.9 228 61.8 27 79.4
Orel 733 257 13.1 270 36.7 206 49.5
a Number of patients reported in this table reﬂects number of patients with available information on variables included in the ﬁnal model.
b Coefﬁcients for the predictive rule to calculate the probability of TI for values of deﬁned factors were obtained based on a ﬁnal logistic regression model for Lipetsk TB
hospital data (expression 1).
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as experience shows that treatment decentralization and outpa-
tient-based treatment improves patient adherence. Despite these
limitations, this study demonstrates robust results for the
prediction of interruptions.
6. Conclusions
We have described the independent predictors of patient TI and
have evaluated these based on routine data from Russian TB
hospitals. The development of a predictive rule for the in-patient
TB treatment phase could allow the identiﬁcation of groups at high
risk for TI and for the provision of targeted interventions. Further
studies are needed to evaluate the risk factors for TI (both in- and
out-patient) and for the adjustment and practical evaluation of the
developed predictive rule. The importance of case management of
retreatment cases should be emphasized.
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